Controversy-free stem cells?

Researchers demonstrate feasibility of altered nuclear transfer to produce ES cells

Written byClementine Wallace
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Researchers have used altered nuclear transfer (ANT) to generate pluripotent murine embryonic stem (ES) cells from blastocysts inherently unable to implant in the uterus. Scientists hope the findings, published in the October 16 issue of Nature, will provide ES cell researchers with a technique that sidesteps the destruction of embryos, triggering ethical controversies.

"This is just one possible approach using ANT, but this study provides the scientific basis for the conversation that could lead us to resolve our nation's impasse over ES cell research," William Hurlbut, from Stanford University, Ca., told The Scientist. Hurlbut was the first to conceive of the idea of ANT, but did not participate in the study.

In another study, published in the same issue of Nature, researchers report using a cell biopsy technique for diagnosing genetic defects to extract ES cells without diminishing the embryo's viability, another technique they hope will help overcome the ethical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery